Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Research Asia Pacific 2018

About Conference


Conference Series LLC Ltd welcomes all the attendees, speakers, sponsors and other research expertise from all over the world to join the Cancer Research Asia Pacific 2018 which is going to be held during  November  12-13, 2018 in Osaka, Japan.

Cancer Research Asia Pacific 2018 coordinates towards tending to fundamental issues and additionally future methodologies  of Cancer. This will be the biggest and most encouraging worldwide meeting where the scientist and in addition leaders will come to talk about and wrangle on different parts of the difficulties, dangers and speculation openings all through the total data of tumors. The program incorporates the total data of growths including malignancy target treatment, Cancer nursing and care, Economic effect on disease, Biomarker and propel utilization of biomarkers, the whole medicinal group associated with tolerant care ,analyst, Professional, early vocation people and patient backers who wish to learn standards of tumor immunology and immunotherapy.

Cancer Research Asia Pacific 2018  is a trending event which brings together efficient international academic scientists, young researchers and students making the congress a perfect platform to share experiences, gain and evaluate emerging technologies in Cancer Treatment and Radiology across the globe. Initiation of cross-border co-operations between scientists and institutions will also be facilitated.

Cancer  are a huge group of illnesses which include irregular cell development with the possibility to attack or spread to different parts of the body. A neoplasm or tumor is a gathering of cells which have experienced unregulated and uncontrolled development and will regularly frame a mass or protuberance, yet might be conveyed diffusely.

Cancer research extensively ranges from epidemiology, molecular level research to the performance of clinical trials to evaluate and compare applications of the various cancer treatments. Many treatment options for cancer exist. The primary ones include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, palliative care and immunotherapy and combined treatment modalities such as chemo-radiotherapy.

Conference Series LLC Ltd organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia with support from 1000 more scientific societies and published 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as Editorial Board Members.

Target Audience:

Cancer Researchers, Scientists, Radiology and Oncology Researchers, Radiology and Oncology Faculty, Medical Colleges, Scientists, Doctors, Professors, Oncology Lecturers, Radiology and Oncology Students, Researchers, Pharmaceutical Industries, Healthcare Industries, Directors of Association and Societies, Cancer and Radiology Training Institutes, Staff development educators.

 

 

 

 

Sessions and Tracks

Cancer

Malignancy is a social event of infections incorporating unpredictable cell improvement with the likelihood to assault or spread to various parts of the body. These emerge from generous tumors, which don't spread to various parts of the body. Conceivable signs and symptoms consolidate a knock, interesting kicking the bucket, deferred hack, unexplained weight decrease, and a change in gut developments. Tobacco utilize is the reason for around 22% of malignancy passings. Another 10% are because of stoutness, terrible eating routine, absence of physical action, and unreasonable drinking of liquor. Different variables incorporate certain contaminations, presentation to ionizing radiation and ecological poisons. In the creating scene, 15% of growths are because of diseases, for example, Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus contamination, Epstein– Barr infection and human immunodeficiency infection.

  • Prostrate cancer
  • Colorectal cancer
  • Oesophagal cancer
  • Breast & ovarian cancer
  • Head and neck cancer
  • Cervical cancer
  • Liver Cancer
  • Pancreatic cancer
  • Brain cancer
  • Gastrointestinal cancer
  • Bile Duct cancer
  • Bladder cancer
  • Bronchial cancer

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,;World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA.

Chemotherapy

Chemotherapy(Chemo) is a sort of treatment that incorporates a pharmaceutical or blend of drugs to treat tumor. The objective of chemo is to stop or moderate the development of growth cells. Chemo is viewed as a foundational treatment. This implies it might influence your whole body. Chemo meds assault quickly developing malignancy cells, yet they can likewise influence solid cells that develop quickly. Chemotherapy is the use of any pharmaceutical to treat any malady. Regardless, to a large number individuals, the word chemotherapy suggests drugs used for ailment treatment. It's every now and again condensed to "chemo." Surgery and radiation treatment expel, murder, or damage illness cells in a particular area, yet chemo can work all through the whole body. This infers chemo can pulverize harm cells that have spread (metastasized) to parts of the body a long way from the principal (fundamental) tumor.

  • Chemotherapy Types
  • Dosage
  • Mechanism of Action
  • Resistance
  • Chemotherapy Side effects

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Disorders in Blood

Iron deficiency is the most surely understood kind of blood issue. Patients with pallor have an inadequacy of oxygen-rich red platelets or their red platelets don't work fittingly. A low level of hemoglobin, the iron-rich protein that passes on the oxygen in red platelets, signals the condition. Anaemia can be steady, or a concise condition caused by other therapeutic issues, including development treatment, hepatitis C, and HIV/AIDS. Iron deficiency from time to time remains unfamiliar in light of the way that it is a key condition of other restorative issues, including development, cardiovascular disease, diabetes, HIV/AIDS, red hot entrail affliction, unending kidney contamination, and rheumatoid joint agony. Hemophilia is an uncommon typical acquired blood issue, generally obtained blood issue which can make hurt organs, joints, and tissues. Patient may encounter the evil impacts of the site of harm or from internal kicking the bucket. Coagulating Disorders Hematologists in like manner treat conditions related to the proteins that trigger depleting and thickening, including thrombosis (thickening) and hemostasis (kicking the bucket). Thrombosis alludes to the development of unusual blood clusters that wind up installed in a noteworthy vein or supply route, blocking blood dissemination. Blood clusters can cause agony, swelling, or warmth in the influenced zone, and can be dangerous. Hemostasis is the way toward controlling dying. Blood Cancers Cancerous blood conditions incorporate leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and different myeloma.

  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Hemophilia A, B and C
  • Von Willebrand
  • Bleeding Disorders
  • Coagulation Factors
  • Hemoglobinopathies
  • Biomarkers for Blood Cancers
  • Platelet Function Defects

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK

Breast cancer

Breast cancer starts in the cells of the bosom. A harmful tumor is a get-together of development cells that can form into and obliterate near to tissue. It can in like manner metastasize to various parts of the body. Cells in the bosom a portion of the time change and never again create or act commonly. These movements may provoke non-dangerous chest conditions, for instance, atypical hyperplasia and bruises. They can in like manner incite non-cancer-causing tumors, for instance, intraductal papillomas.

  • Breast cancer screening
  • Reconstruction
  • Lobular carcinoma
  • Abortion–breast cancer hypothesis

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Haematologist-oncology

A hematologist-oncologist is a doctor who works in the analysis, treatment and additionally counteractive action of blood illnesses and malignancies, for example, press insufficiency sickliness, hemophilia, sickle-cell ailment, leukemia and lymphoma. This doctor is prepared in hematology — the investigation of blood — and oncology — the investigation of malignancy. Hematologist-oncologists don't for the most part regard operable diseases, for example, prostate tumor, however have some expertise in treating blood malignancies Hematologic malignancies are kinds of disease that begins in the cells of blood-forming tissue, for instance, the bone marrow, or in the cells of the safe framework. Instances of hematologic illness are exceptional and perpetual Leukemia, lymphomas, and various myeloma and myelodysplastic issue. Myeloproliferative neoplasms, or MPNs, are hematologic developments that emerge from risky hematopoietic myeloid forebear cells in the bone marrow, for instance, the forerunner cells of red cells, platelets and granulocytes .Included in the MPN sickness range are fundamental thrombocythemia, polycythemia Vera and myelofibrosis . This intelligent session will focus on an extensive variety of typical or unprecedented blood tumors, for instance, extreme promyelocytic Leukemia (APL) and relentless myelomonocytic Leukemia bristly cell Leukemia (HCL), sweeping granular lymphocytic Leukemia (LGL), white platelet serious lymphoblastic Leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic– Myeloproliferative infection. The gauge of how the ailment will go for a patient is called anticipation. There are numerous variables impact visualization that include: the sort of tumor and where it is in the body, the period of the malignancy, the disease review. Graduate gives signs about how quickly the infection is most likely going to create and spread certain attributes of the tumor cells, the age and how sound body was before growth and how productive is the treatment.

  • Haemophilia
  • Bone marrow disease
  • Anticoagulation therapy
  • Blood transfusion

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan.

Gynecologic Cancer Prevention and Control

A move from treatment to balancing activity of the three significant gynecologic ailments: Cervical tumor remains the fourth most customary sickness, impacting women worldwide with immense geographic assortments in cervical threat recurrence and passing rates.. Essentially as with other such contaminations, obstacle and spermicidal contraceptives cut down the risk of cervical tumor; the perils diminish estimated half. Combinational contraceptives help expect both endometrial and epithelial ovarian tumors. The peril of endometrial tumor among past oral protection customers is diminished by around half and that of ovarian harm by around 30% to 80%. Weight control presents strong affirmation against endometrial development. Bosom encouraging and tubal sanitization appears to guarantee against ovarian development. Regardless of the way that women have an extension, of down to earth, viable measures open to reduce their peril of these malignancies, and few think about them. A couple of affirmation based intercessions are open to diminish the event, bleakness, and mortality from these developments. The National Comprehensive Cancer Control Program (NCCCP) is astoundingly arranged to realize these mediations in the US populace.

  • Prevention of cervical cancer
  • Prevention of vulvar cancer
  • Prevention and early detection of vaginal cancer
  • Prevention of epithelial ovarian cancer

 

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA;.International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain.

Clinical Oncology

Clinical Oncology includes Medical Oncology (MO), Surgical Oncology (SO), Gynecologic Oncology, Hematologic Malignancies .Medical oncology communicates the results of clinical and experimental research in oncology and haematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. A surgical and non-surgical oncologist specializes in the removal of the tumours and surrounding tissue during an operation. A surgical also performs biopsies (the removal of a small amount of tissue for examination under a microscope). Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Werner syndrome (WS), also known as "adult progeria is a rare, autosomal recessive progeroid syndrome (PS), which is characterized by the appearance of premature aging. Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Pediatric Oncology

Pediatric oncologists are the physicians who have specialized in pediatrics and then received further training in medical oncology and hematology. This means that rather than using surgery or radiation therapy to treat cancer, pediatric oncologists typically use medications and chemotherapy. Myeloid leukemia is a type of leukemia affecting myeloid tissue. In medicine, histiocytosis refers to an excessive number of histiocytes, (tissue macrophages), and is typically used to refer to a group of rare diseases which share this as a characteristic. Occasionally and confusingly, the term "histiocytosis" is sometimes used to refer to individual diseases. Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia (ALL) is an acute form of leukaemia, or cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblasts. A brain tumour or intracranial neoplasm occurs when abnormal cells form within the brain. There are two main types of tumours: malignant tumours and benign tumours.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; 2nd  Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Radiation oncology

Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A Radiation Oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Brachytherapy is an advanced cancer treatment. Radioactive seeds or sources are placed in or near the tumour itself, giving a high radiation dose to the tumour while reducing the radiation exposure in the surrounding healthy tissues. External beam therapy (EBT), also called external radiation therapy, is a method for delivering a beam or several beams of high-energy x-rays to a patient's tumour. Intraoperative radiation therapy, or IORT is the application of therapeutic levels of radiation to the tumour bed while the area is exposed during surgery. Systemic radiation therapy is a type of radiation therapy in which radioactive material travels through the bloodstream to reach cells all over the body. Systemic radiation is used to treat certain types of cancer, such as thyroid cancer, or to relieve pain when cancer has spread (metastasized) to the bone. Radio immunotherapy (RIT) uses an antibody labelled with a radionuclide to deliver cytotoxic radiation to a target cell. In cancer therapy, an antibody with specificity for a tumour-associated antigen is used to deliver a lethal dose of radiation to the tumour cells.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA

Organ Specific Cancer

Brain and spinal cord tumours may be either benign (not cancer) or malignant (cancer).Both benign and malignant tumours cause signs and symptoms and need treatment. Benign brain and spinal cord tumours grow and press on nearby areas of the brain but rarely spread into other parts of the brain. Malignant brain and spinal cord tumours are likely to grow quickly and spread into other parts of the brain. The bones around the nasal cavity have small hollow spaces in them called paranasal sinuses. These sinuses affect the sound and tone of voice. The exact causes of nasal and sinus cancers are not known. Cancers that are known collectively as head and neck cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). The most dangerous form of skin cancer is these cancerous growths develop once unrepaired DNA damage to skin cells most frequently caused by ultraviolet radiation from sunshine or tanning beds triggers mutations genetic defects that lead the skin cells to multiply rapidly and form malignant tumors. Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin. Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Pulmonary metastases of renal cell carcinoma (RCC) are associated with poor prognosis. Inhalation therapy with interleukin-2 (IL-2) is thus an appealing method for palliation. Carcinoma of the thyroid gland is an uncommon cancer but is the most common malignancy of the endocrine system. Differentiated tumours (papillary or follicular) are highly treatable and usually curable. Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer. Most cases of HCC are secondary to either a viral hepatitis infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of liver cirrhosis). Reproductive cancers start in the organs related to reproduction. These organs are located in the pelvis. The pelvis is the area in the lower belly between the hip bones.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain;

Cancer: Diagnostics and Staging

X-radiation (composed of X-rays) is a form of electromagnetic radiation Magnetic resonance imaging (MRI) is a type of scan that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. An ultrasound scan, sometimes called a sonogram, is a procedure that uses high-frequency sound waves to create an image of part of the inside of the body. A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist involving sampling of cells or tissues for examination. A complete blood count (CBC) gives important information about the kinds and numbers of cells in the blood, especially red blood cells camera.gif, white blood cells camera.gif, and platelets. Cancer staging is the process of determining the extent to which a cancer has developed by spreading. The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that gives codes to describe the stage of a person's cancer, when this originates with a solid tumour. Pathologic staging, where a pathologist examines sections of tissue, can be particularly problematic for two specific reasons: visual discretion and random sampling of tissue.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain

Cancer: Treatment and Therapy

Various therapeutics are now available to treat cancer.. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. Hyperthermia is elevated body temperature due to failed thermoregulation that occurs when a body produces or absorbs more heat than it dissipates.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain;

 

Cancer Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis.  The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,;World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA.

Cancer: Lifestyle and Nutrition

Cancer is to a great extent an inherited infection, as though destiny and the family quality pool alone direct your odds of becoming ill. A routine is key to tumor foresight, especially a regimen focused on settling on nutritious choices, favoring regular sustenance, eating with some restriction and planning nourishments legitimately . It's about modify, control and combination. By eating the right support, using an extensive variety of supplements and not eating up more than your body requires, you can help diminish your peril of harm and diverse diseases.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan,; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK.

 

Market Analysis

Market Analysis for  CANCER RESEARCH ASIA PACIFIC 2018

Oncology is the term used for the study of the cancer and it is branch of medicine. Doctor who specializes in the Cancer is known as Oncologist. The vital role of the oncologist is to diagnose the people who are suffering from the cancer and explain the adverse effects during the treatment. There are different types of Oncologists in treating the cancer. Medical Oncologist treats the cancer with the chemotherapy process. Surgical Oncologist involves in the removal of the tumour and the surrounded tissue during the surgery. Radiation Oncologist used to treat the cancer with the Radiation therapy.

Cancer is a common term for a large group of diseases that can affect any organ of the body. Other terms used are malignant tumours and neoplasms. One of the significant features of cancer is the rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death from cancer. Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries.

Scope and Importance

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.

Cancer is the leading cause of death in the Dubai. The incidence of all cancers is projected to 20% increase by 2010-2030, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among UAE females (and the most prevalent cancer in both sexes combined), lung cancer, prostate cancer and bowel caners are the most common cancers amongst males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively).

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Lung cancer is one of the most aggressive tumors and survival after five years is   very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

Colorectal cancer (of the colon and rectum), the most common malignant tumors if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.Prostate cancer, today the most common tumors in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Oncology Conferences are intended to provide a medium for the communication of results and ideas in the field of cancer science and Treatment regarding to cancers. The conference welcomes contributions in both the basic and clinical aspects of the cancer science and special sections on the Health Care and a forum for Innovative topics related to the cancer science.

ConferenceSeries LLC Ltd welcomes all the oncologists, radiologists, pathologists, Immunologists research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Oncologists. As this will be the best amalgamation of academia and research involving every aspect and advances in the field of Oncology & cancer. It is open to all types of research methodologies both from academia and industry

Key Benefits

  • In-depth analysis of the drugs in the market for treatment of ovarian cancer would help in understanding the capacity for growth in this market 
  • Segmentation by geography would help in identifying the demand for ovarian drugs in each region 
  • Key drivers and opportunities would help in a deeper understanding of the scope of the market
  • Porter’s five-force model would give a clear picture of the market and help in making business decisions
  • Estimations have been given for the period from 2013 to 2020, which would help in identifying the potential of the market

Key Deliverables

The  Cancer drug market is segmented by drugs and geography. 

By Drug

  • Paclitaxel
  • Cisplatin
  • Adriamycin PFS (Doxorubicin Hydrochloride)
  • Carboplatin
  • Cyclophosphamide
  • Platinol (Cisplatin)
  • Paraplatin (Carboplatin)
  • Doxorubicin Hydrochloride Liposome
  • Evacet (Doxorubicin Hydrochloride Liposome)
  • Cytoxan (Cyclophosphamide)
  • Paraplat (Carboplatin)
  • Taxol (Paclitaxel)
  • Neosar (Cyclophosphamide)
  • Gemcitabine Hydrochloride
  • Platinol-AQ (Cisplatin)
  • Topotecan Hydrochloride
  • Gemzar (Gemcitabine Hydrochloride)
  • Hycamtin (Topotecan Hydrochloride)
  • Doxorubicin Hydrochloride
  • LipoDox (Doxorubicin Hydrochloride Liposome)
  • Dox-SL (Doxorubicin Hydrochloride Liposome)
  • Clafen (Cyclophosphamide)
  • Adriamycin RDF (Doxorubicin Hydrochloride)
  • DOXIL (Doxorubicin Hydrochloride Liposome)

Top Oncology Drugs:

Avastin, Alimta, Xeloda,Tarceva, Zometa, Sutent, Nexavar,Revlimid,Opdivo,Imbruvica

Keytruda,Ibrance,Tecentriq, Darzalex, Perjeta, Xtandi, Herceptin, Gazyva, Jakafi, Venclexta

Why Japan?  

Japan is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Japanese outcomes for high level medical treatment are generally competitive with that of the US. A comparison of two reports in the New England Journal of Medicine  suggest that outcomes for gastro-oesophageal cancer is better in Japan than the US in both patients treated with surgery alone and surgery followed by chemotherapy. Japan excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Japan Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Japan for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. A comparison of the data from United States Renal Data System (USRDS) 2009 and Japan Reno logy Society 2009 shows that the annual mortality of patients undergoing dialysis in Japan is 13% compared to 22.4% in the US. Five-year survival of patients under dialysis is 59.9% in Japan and 38% in the US.

   Cancer Universities in Japan

  • National Cancer Centre Hospital
  • Aichi Cancer Centre
  • Kyoto Prefectural University of Medicine
  • Tohoku University
  • Kyoto University
  • Chiba University
  • Osaka University

Universities Worldwide

  •  University of Oxford
  • University of Cambridge
  • UCL London's Global University
  • Stanford University
  • Western University
  • University of Nottingham
  • University of Bologna
  • University of Athens
  • University of Chicago
  • University of Washington
  • University of Rochester
  • The University of Melbourne
  • University of Glasgow
  • Fudan University
  • Stanford University
  • University of Minnesota
  • University of Albert
  • University of Nebraska
  • University of Iowa Carver
  • University of Pennsylvania
  • South-western University
  • University of Pittsburgh
  • University of Helsinki
  • University of Penn Medicine

  Universities in Asia

  • Osaka University
  • Tsinghua University
  • Fudan University
  • Taipei Medical University
  • KAIST - Korea Advanced Institute of Science and Technology
  • Yonsei University
  • Shanghai Jiao Tong University
  • Nanyang Technological University (NTU)
  • Chulalongkorn Universit
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan Universit
  •  Indian Institute of Science
  • University Kebangsaan Malaysia (UKM)
  • University Saints Malaysia (USM)
  • Beijing University of Chinese Medicine
  • National Tsing Hua University

Worldwide Societies Associated with Cancer

  • American Cancer Society
  • American Association for Cancer Research
  • The Cancer Association of South Africa
  • National Cancer Society Malaysia
  • Kidney Cancer Association
  • Singapore Cancer Society
  • Cancer Association of Namibia
  • European Oncology Nursing Society
  • Oncology Nursing Society
  • International Society of Nurses in Cancer Care
  • Association of Pediatric Hematology/Oncology Nurses
  • Cancer Nurses Society of Australia

 

 

To Collaborate Scientific Professionals around the World

Conference Date November 12-13, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Chemotherapy: Open Access Journal of Integrative Oncology Advances in Oncology Research and Treatments

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos